Recent advances in dimensional imaging, surgical technique, and perioperative patient care have resulted in increased rates of complete resection with histopathologically negative margins and improved surgical outcomes in patients with extrahepatic cholangiocarcinoma. However, achieving cancer-free resection margins at ductal stumps in surgery for this disease remains challenging because of longitudinal extension, which is one of the hallmarks of extrahepatic cholangiocarcinoma. When the ductal resection margins are shown to be positive on examination of frozen sections, discrimination between carcinoma in situ and invasive carcinoma is clinically important because residual carcinoma in situ may lead to late local recurrence whereas residual invasive carcinoma is associated with early local recurrence. Residual invasive carcinoma at the ductal margins should be avoided whenever technically feasible. Residual "carcinoma in situ" at the ductal margins appears to be allowed in resection for the advanced disease because it has less effect on survival than other adverse prognostic factors (pN1 and/ or pM1). However, in surgery for early-stage (pTis-2N0M0) extrahepatic cholangiocarcinoma, residual carcinoma in situ at the ductal margins may have an adverse effect on long-term survival, so should be avoided whenever possible. In this review, we focus on the histopathological term "carcinoma in situ," the biological behavior of residual carcinoma in situ at ductal resection margins, intraoperative histological examination of the ductal resection margins, outcome of additional resection for positive ductal margins, and adjuvant therapy for patients with positive margins.
histopathologically negative margins and improved patient survival in patients with extrahepatic cholangiocarcinoma. [3] [4] [5] [6] However, cancerfree resection margins at the bile duct stump are difficult to achieve because of longitudinal extension, which is one of the prominent characteristics of extrahepatic cholangiocarcinoma. 11, 12 Ductal resection margin status is an established prognostic indicator, 13,14 and survival following resection in patients with positive ductal margins has generally been deemed unsatisfactory. 10, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] In 2005, Wakai et al 26 reported that invasive carcinoma at the ductal resection margins had a strong adverse effect on survival in patients with extrahepatic cholangiocarcinoma, whereas residual carcinoma in situ did not. Thereafter, similar results were reported in Japan, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] the USA, 37 South Korea, 38, 39 and Germany. 40 These findings indicate that discrimination between carcinoma in situ and invasive carcinoma is critical when the ductal resection margins are found to be positive on intraoperative examination of frozen sections; residual carcinoma in situ may lead to late local recurrence, whereas residual invasive carcinoma results in early local recurrence. 26 Herein, we review the surgical management of carcinoma in situ at the ductal resection margins in patients undergoing curative-intent resection for extrahepatic cholangiocarcinoma, including perihilar cholangiocarcinoma and distal bile duct cancer. This review focuses on the histopathological term "carcinoma in situ," its biological behavior at the ductal resection margins, intraoperative histological examination of these margins, outcome of additional resection for positive ductal margins in perihilar cholangiocarcinoma, and adjuvant therapy for patients with positive ductal margins.
| " CARCINOMA IN SITU" : HISTOPATH OLOGICAL TERMINOLOGY
In the WHO International Histological Classification of Tumours: His- Distinction between these intramural epithelial lesions (pseudoinvasion) and invasive carcinoma is now made according to the histological criteria defined by Albores-Saavedra et al. 42 The term "intraepithelial neoplasia" (encompassing dysplasia and carcinoma in situ) was initially used in the WHO Classification of Tumors classified as Tis cytologically resemble carcinoma, with diffuse and severe distortion of cellular polarity, but invasion through the basement membrane is absent.
| BIOLOGICAL BE HAVIOR OF RESIDUAL

CARCINOMA IN SITU
Reported incidences of residual carcinoma in situ and invasive carcinoma at the ductal resection margins in patients who have undergone resection of extrahepatic cholangiocarcinoma have been in the range of 3%-16% and 8%-18.3%, respectively (Table 1) . [26] [27] [28] 31, 32, 34, 35, 38 The reported incidences of complete resection with histopathologically negative margins ranged from 69% to 87%. [26] [27] [28] 31, 32, 34, 35, 38 All the studies included in Table 1 confirmed that ductal resection margin status was an independent prognostic factor in patients with extrahepatic cholangiocarcinoma.
Residual invasive carcinoma at the ductal resection margins (median survival time, 12-21 months) has been reported to influence patient survival after surgical resection for extrahepatic cholangiocarcinoma more adversely than residual carcinoma in situ (median survival time, 
29-99 months
| OUTCOME OF ADDITIONAL RESECTION FOR CARCINOMA-POSITIVE DUCTAL MARGINS
In clinical practice, additional intraoperative resection of the proximal bile duct is often carried out for perihilar cholangiocarcinoma to obtain a negative ductal margin based on examination of frozen sections. However, the impact of this practice on the surgical outcomes of perihilar cholangiocarcinoma remains controversial (Table 2 ). In 2008, Endo et al 37 reported on the clinical significance of proximal ductal resection margins in 101 patients with perihilar cholangiocarcinoma. They divided the proximal ductal resection margin status of these patients into three categories based on final pathological examination as follows: a wide margin (both an additional ductal resection margin and specimen margin negative, n = 54), a narrow margin (an additional ductal resection margin negative but specimen margin positive, n = 28), and a positive margin (both an additional ductal resection margin and specimen margin positive, n = 19). 37 Survival in patients with a narrow margin was significantly worse than that in patients with a wide margin and was comparable with that in patients with a positive margin ( Table 2) . 37 The results of their study suggested that surgical outcome is not altered by extending the resection of the proximal bile duct in most patients with perihilar cholangiocarcinoma.
Shingu et al 57 reported the clinical importance of additional resection for positive proximal bile duct margins in 303 patients with perihilar cholangiocarcinoma, 12 of whom underwent additional resection after invasive carcinoma at the ductal margins was confirmed by frozen section examination. In all 12 patients, the length of the additional resection was ≤5 mm and a negative ductal margin was obtained by additional resection in 8 patients. 57 Their results indicated that such limited resection (≤5 mm) for a positive proximal ductal margin was not associated with improved survival, even when a negative ductal margin was obtained by additional resection (Table 2) . They proposed one possible reason for their results. All 8 patients with a negative proximal ductal margin after additional resection had at least one independent prognostic factor that contributed strongly to worse survival; for such patients, clearance of the proximal ductal margin might not confer any survival benefit because the status of the ductal margins has a less powerful influence on the outcome. 57 In contrast, Ribero et al 63 reported that additional resection of a positive proximal ductal margin offered a survival benefit in patients with perihilar cholangiocarcinoma. In their study, survival in patients with a negative proximal ductal margin achieved by additional resection was comparable with that in patients with a primary negative proximal margin and was significantly better than that in patients with a positive ductal margin (Table 2) . They recommended that additional resection should be attempted for a positive proximal ductal margin whenever possible. 63 Oguro et al 64 attempted to clarify the optimal indications for additional resection of a positive proximal ductal margin in 224 patients with perihilar cholangiocarcinoma. Additional resection of a positive proximal ductal margin afforded no survival benefit in this study (Table 2 ). However, they demonstrated that, in the subgroups with a CA 19-9 level <64 U/mL and pM0 disease, survival in patients with a negative proximal ductal margin who underwent additional resection was significantly better than that in patients with a positive proximal ductal margin. In addition, they attributed the inconsistent results between the different studies of the effect of additional resection of a positive proximal ductal margin on outcomes to differences in the tumor characteristics of the study population. The rates of Bismuth type IV disease in the studies by Oguro et al 64 and
Shingu et al 57 were reported to be 40% and 38.9%, respectively, whereas the rate was 14.6% in the study by Ribero et al. 63 This suggests that the study by Ribero et al 63 (Table 2) . They concluded that every attempt should be made to achieve a carcinoma-negative ductal margin when technically feasible. In their study, 65 the rate of Bismuth type IV disease was 22.6%, which was lower than the rates in the Eastern centers reported by Oguro et al 64 and Shingu et al. 57 Recently, Tsukahara et al 34 reported the clinical importance of additional resection for a carcinoma in situ-positive ductal margin in patients with early-stage (Tis-T2N0M0) cholangiocarcinoma. In their study, 12 patients underwent additional resection for carcinoma in situ at a ductal resection margin and a negative margin was achieved after additional resection in 7 patients. Survival in these 7 patients was comparable with that in patients with a primary negative margin for both invasive carcinoma and carcinoma in situ and was significantly better than that in patients with a carcinoma in situ-positive ductal margin. The findings of that study suggest that additional resection for carcinoma in situ at the ductal resection margins confers a survival benefit in patients with early-stage cholangiocarcinoma, with the caveat that a limited number of patients were investigated. Further studies are warranted to confirm the efficacy of this practice.
| ADJUVANT THERAPY
Although surgery affords the only chance of cure in patients with extrahepatic cholangiocarcinoma, the surgical outcomes remain poor because of a high rate of recurrence. Despite curative-intent resection, positive ductal resection margins are sometimes confirmed after pathological examination. Adjuvant therapy has been advocated to improve these poor outcomes. [66] [67] [68] [69] [70] [71] However, given the rarity of extrahepatic cholangiocarcinoma, most of the data regarding adjuvant therapy have come from small, single-center studies or retrospective single-arm reviews. Recent relatively large studies and systematic In this study, both proximal and distal ductal resection margin status were evaluated. Primary R0, a negative ductal resection margin without additional resection; Secondary R0, a negative ductal resection margin with additional resection; R1, a microscopic positive ductal resection margin; MST, median survival time; ND, not described; NS, not statistically significant.
reviews/meta-analyses have suggested that adjuvant chemoradiotherapy, radiotherapy, or chemotherapy are associated with improved survival in patients with biliary tract cancer and high-risk characteristics, including positive ductal resection margins. [66] [67] [68] However, the intention-to-treat analyses in all the large randomized clinical studies of adjuvant chemotherapy for biliary tract cancer reported thus far have failed to demonstrate its efficacy. [69] [70] [71] Therefore, the effective adjuvant chemotherapy regimen for this disease entity remains undetermined. Further clinical trials of adjuvant treatment focusing on patients with high-risk characteristics are needed to resolve this problem. In the meantime, adjuvant therapy should be considered as a multimodal treatment option for patients with extrahepatic cholangiocarcinoma in whom positive ductal resection margins are confirmed after surgical resection.
| CONCLUSIONS
Clinically, discrimination between carcinoma in situ and invasive car- 
